Cargando…
Strontium-89 therapy for the treatment of huge osseous metastases in prostate carcinoma: A case report
Prostate cancer is a growing public health problem. The palliation of pain in patients with painful bone metastases is of primary importance in the clinical management of advanced cancer. Internal therapy with radionuclides, which concentrate at sites of increased bone turnover, is used to control p...
Autores principales: | ZHANG, WENJIE, ZHAO, WEIWEI, JIA, ZHIYUN, DENG, HOUFU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570111/ https://www.ncbi.nlm.nih.gov/pubmed/23404044 http://dx.doi.org/10.3892/etm.2012.807 |
Ejemplares similares
-
89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes.
por: Fosså, S. D., et al.
Publicado: (1992) -
Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer
por: Turner, S L, et al.
Publicado: (2001) -
Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron)
por: Heianna, Joichi, et al.
Publicado: (2014) -
In Vitro Study on Apoptosis Induced by Strontium-89 in Human
Breast Carcinoma Cell Line
por: Wang, Cheng, et al.
Publicado: (2011) -
Papillary Carcinoma Thyroid Presenting as Huge Scalp Metastases
por: Barwad, Adarsh, et al.
Publicado: (2018)